| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/19/2000 | EP0993831A2 Compounds and compositions for delivering active agents |
| 04/19/2000 | EP0993450A1 New compounds |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | EP0586520B1 Backbone modified oligonucleotide analogs |
| 04/19/2000 | CN1051544C Benzenesulfonamide derivative and process for preparing thereof |
| 04/18/2000 | US6051710 Useful intermediates in the preparation of pyrimidinones |
| 04/18/2000 | US6051669 Polymers from certain conjugated organic compounds |
| 04/18/2000 | US6051561 Compounds and compositions for delivering active agents |
| 04/18/2000 | US6051288 Large dielectric anisotropy, small change in threshold voltage depending on temperature, and an improved solubility to other liquid crystal materials at low temperatures |
| 04/18/2000 | CA2194080C Novel process for preparing 2,6-di(4,6-dimethoxypyrimidin-2-yl) oxybenzoic acid oxime ester derivatives |
| 04/18/2000 | CA1340962C Arylhydrazones |
| 04/16/2000 | CA2252144A1 Dual action anticancer prodrugs |
| 04/13/2000 | WO2000020556A2 Zinc finger-reactive antimicrobial compounds |
| 04/13/2000 | WO2000020402A1 Chemical compounds |
| 04/13/2000 | WO2000020357A2 Chemical constructs |
| 04/13/2000 | WO2000020112A2 Chemical constructs and their uses |
| 04/13/2000 | WO2000020023A2 Null igf for the treatment of cancer |
| 04/13/2000 | CA2345212A1 Zinc finger-reactive antimicrobial compounds |
| 04/13/2000 | CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 04/12/2000 | EP0992501A2 Pyridonecarboxylic acid derivatives as antibacterial agents |
| 04/12/2000 | EP0992498A1 Aromatic fatty acid esters |
| 04/12/2000 | EP0991653A1 Novel compounds |
| 04/12/2000 | EP0991631A1 Substituted aminoheterocyclylamides |
| 04/12/2000 | EP0991627A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/12/2000 | EP0991626A2 Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds |
| 04/12/2000 | CN1250442A Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
| 04/12/2000 | CN1250435A Phenoxyacetic acid derivatives and their use as herbicides |
| 04/12/2000 | CN1051307C 3-(hetero) aryloxy (thio) carboxylic acid derivatives, herbcide and plant-growth regulator and method |
| 04/12/2000 | CN1051306C Process for producing pyrrolopyrimidines and intermediates therefor |
| 04/12/2000 | CN1051305C Acylated aminophenyl urea compounds, their preparation and their use as herbicides and plant-growth regulators |
| 04/11/2000 | US6048883 Hypoglycemic agent |
| 04/11/2000 | US6048866 Substituted 2-anilinopryimidines useful as protein kinase inhibitors |
| 04/11/2000 | CA2120725C Chemical compounds |
| 04/11/2000 | CA2082617C Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method |
| 04/06/2000 | WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 04/06/2000 | WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/05/2000 | EP0990439A1 Bisaryl compounds and cancer remedies containing the same |
| 04/05/2000 | EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | CN1051074C Use of isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides for preparing medicine |
| 04/04/2000 | US6046330 Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts |
| 04/04/2000 | US6046329 Uracil derivatives |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/30/2000 | WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/30/2000 | CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/29/2000 | EP0988863A2 Stable complexes of poorly soluble compounds |
| 03/29/2000 | EP0988291A1 Method for producing quinazoline-diones in solid phase and use of the same |
| 03/29/2000 | EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses |
| 03/29/2000 | CN1248972A Cycloimido-substituted benzofused heterocyclic herbicides |
| 03/29/2000 | CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use |
| 03/28/2000 | US6043255 Muscarinic antagonists |
| 03/28/2000 | US6043250 Treating or preventing inflammatory diseases |
| 03/28/2000 | US6043248 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 03/28/2000 | US6043240 Useful as antipsychotic and analgesic agents |
| 03/28/2000 | US6043218 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| 03/28/2000 | US6043196 Herbicidal sulfonylureas, their preparation and use |
| 03/28/2000 | US6042745 Electrooptical liquid crystal system |
| 03/28/2000 | CA2180658C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2016106C Mesomorphic compound, liquid crystal composition containing same and liquid crystal device using same |
| 03/28/2000 | CA2001003C Olefinically unsaturated compounds, a process for the production of copolymers containing isocyanate groups, the copolymers thus obtained and coating compositions or sealing compounds containing the copolymers |
| 03/23/2000 | WO2000015634A2 Hiv protease inhibitors |
| 03/23/2000 | WO2000015614A1 Novel compounds |
| 03/23/2000 | WO2000015230A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 03/23/2000 | WO2000015229A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | WO1999046316A3 Enzyme inhibitors |
| 03/23/2000 | CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination |
| 03/23/2000 | CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination |
| 03/23/2000 | CA2341440A1 Novel compounds |
| 03/23/2000 | CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors |
| 03/22/2000 | EP0987255A2 Substituted aminoquinazolinone (thione) derivatives |
| 03/22/2000 | EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 03/22/2000 | EP0986551A1 Sulfonamide derivatives, their production and use |
| 03/22/2000 | EP0986543A1 Substituted arylalkyl uracils |
| 03/22/2000 | EP0986542A1 Fluoromethoximino compounds |
| 03/22/2000 | EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0790997B1 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 03/22/2000 | CN1248251A Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 03/22/2000 | CN1248248A Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists |
| 03/21/2000 | US6040448 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands |
| 03/21/2000 | US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal |
| 03/21/2000 | US6040317 Sulfonamide fibrinogen receptor antagonists |
| 03/21/2000 | US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal |
| 03/16/2000 | WO2000014174A1 Organic electroluminescence device and phenylenediamine derivative |
| 03/16/2000 | WO2000014063A1 Therapeutic compounds and methods |
| 03/16/2000 | WO2000013708A1 Methods for treating or preventing viral infections and associated diseases |
| 03/16/2000 | WO2000013508A1 Fused-benzene derivatives useful as herbicides |
| 03/16/2000 | CA2343522A1 Methods for treating or preventing viral infections and associated diseases |
| 03/16/2000 | CA2342858A1 Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv |
| 03/15/2000 | EP0985415A1 Uracil reductase inactivators |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984945A1 Substituted iminoalkoxy-phenyluracils, the production and use thereof as herbicides |
| 03/15/2000 | EP0984778A1 Neuropeptide-y ligands |